DENND4A (DENN domain containing 4A) functions as a guanine nucleotide exchange factor (GEF) that regulates RAB10 GTPase signaling. As a GEF, DENND4A catalyzes the exchange of GDP for GTP on RAB proteins, converting them from their inactive to active state. DENND4A localizes to the retrieval sub-domain of endosomes, where it associates with the Retromer complex to regulate endosomal cargo recycling and RAB10 switching 1. This function is critical for maintaining proper vesicular trafficking and cellular homeostasis. At the molecular level, DENND4A is subject to translational regulation by the RNA-binding protein TDP-43. TDP-43 patient mutations associated with amyotrophic lateral sclerosis and frontotemporal dementia can enhance translation of DENND4A mRNA through specific 3'UTR elements 2, potentially linking altered DENND4A expression to neurodegeneration. Beyond its canonical GEF function, DENND4A shows hypermethylation in vascular cognitive impairment patients 3, suggesting epigenetic dysregulation in neurodegenerative disease. The clinical significance of DENND4A is primarily rooted in its role in endosomal trafficking and neuroprotection. As a component of the Retromer-organized retrieval sub-domain hub that regulates RAB GTPase switching, DENND4A likely contributes to the neuroprotective functions of this complex 1. Its dysregulation through both transcriptional and epigenetic mechanisms appears relevant to neurodegenerative diseases including neuroinflammatory conditions and vascular cognitive impairment.